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Abstract
Aims/hypothesis In contrast to insulin-resistant individuals,
insulin-sensitive athletes possess high intramyocellular lipid
content (IMCL), good mitochondrial function and high
perilipin 5 (PLIN5) levels, suggesting a role for PLIN5 in
benign IMCL storage. We hypothesised a role for PLIN5 in
modulating fasting-mediated insulin resistance.
Methods Twelve men were fasted for 60 h, before and after
which muscle biopsies were taken and stained for lipid drop-
lets (LDs), PLIN5 and laminin. Confocal microscopy images
were analysed for LD size, number, PLIN5 association and
subcellular distribution.
Results Fasting elevated IMCL content 2.8-fold and reduced
insulin sensitivity (by 55%). Individuals with the most prom-
inent increase in IMCL showed the least reduction in insulin
sensitivity (r=0.657; p=0.028) and mitochondrial function
(r=0.896; p=0.006). During fasting, PLIN5 gene expression
or PLIN5 protein content in muscle homogenates was unaf-
fected, microscopy analyses revealed that the fraction of
PLIN5 associated with LDs (PLIN5+) increased signifi-
cantly (+26%) upon fasting, suggesting PLIN5 redistribu-
tion. The significant increase in LD number (+23%) and
size (+23%) upon fasting was entirely accounted for by
PLIN5+ LDs, not by LDs devoid of PLIN5. Also the asso-
ciation between IMCL storage capacity and insulin resis-
tance and mitochondrial dysfunction was only apparent for
PLIN5+ LDs.
Conclusions/interpretation Fasting results in subcellular
redistribution of PLIN5 and promotes the capacity to store
excess fat in larger and more numerous PLIN5-decorated
LDs. This associates with blunting of fasting-induced insulin
resistance and mitochondrial dysfunction, suggesting a role
for PLIN5 in the modulation of fasting-mediated lipotoxicity.
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Rd Rate of disappearance
SI-index Insulin sensitivity index
Introduction
Excess lipid can be stored ectopically as triacylglycerol in
lipid droplets (LDs) (e.g. in skeletal muscle). This is often
associated with compromised myocellular insulin sensitivity
[1–3]. Rodent studies revealed that a high-fat diet increases
intramyocellular lipid (IMCL) content and promotes insulin
resistance [4]. Acute elevation of lipid availability in humans
profoundly augments IMCL storage and insulin resistance [5].
How excess fat storage in muscle affects insulin sensitivity,
however, is not yet clear.
Excess fat in muscle is stored in LDs containing predomi-
nantly neutral lipids like triacylglycerol and cholesteryl esters.
LD size [6], subcellular distribution [7–9] and composition
[10] and interaction of LDs with other cellular organelles like
mitochondria [11] have all been postulated to contribute to the
observed association between IMCL storage and insulin resis-
tance. Paradoxically, stimulating muscle fat storage by over-
expressing diacylglycerol-O-acyltransferase-1 (DGAT1) pro-
foundly augments IMCL storage [12] without compromising
insulin sensitivity [13, 14]. Moreover, endurance-trained
athletes have high levels of IMCL while being very sensitive
to insulin [15] and are less sensitive to acute lipid-induced
insulin resistance upon lipid infusion [5]. In searching for a
unifying factor in conditions of maintained insulin sensitivity
despite the presence of high levels of IMCL, we noticed that in
all conditions when insulin sensitivity was maintained even
though IMCL was high or elevated, the gene expression
or protein content of perilipin 5 (PLIN5) was increased [13,
16, 17].
PLIN5 is a member of the perilipin LD coat proteins and is
predominantly expressed in metabolically active tissues
[18–20] where it appears to regulate oxidative LD lipolysis
[21] and hence affects LD size. To examine the effect of
PLIN5 on lipid-induced insulin resistance we overexpressed
PLIN5 in rat skeletal muscle and observed a profound in-
crease in intramyocellular LD content while insulin-
stimulated glucose uptake was not impaired [22]. In line with
this observation, it has recently been shown that whole-body
deletion of PLIN5 in mice reduced insulin-mediated glucose
uptake [23]. Of the other perilipin family members present in
muscle, perilipin 2 (PLIN2) has also been reported to promote
the retention of lipids in LDs and to prevent high-fat-diet-
induced reductions in insulin sensitivity [24] whereas
perilipin 3 (PLIN3) has recently been associated with fat
oxidation in cultured muscle cells [25]. To date, PLIN5 is
the only member of the perilipin family that has been directly
linked to LD turnover and fat oxidation in multiple models of
insulin resistance [26]. Thus, we focused on PLIN5 and
hypothesised that elevation of PLIN5 contributes to the main-
tenance of insulin sensitivity under conditions of an abun-
dance of lipids. Under pathophysiological conditions like
type 2 diabetes, insulin resistance of adipose tissue results
in disinhibition of adipose tissue lipolysis by insulin. Thus,
the pathological state of type 2 diabetes creates a situation in
which glucose, insulin and plasma NEFA are elevated.
Although the putative effects of insulin on lipolysis of
myocellular LDs has not been studied in detail, it has been
reported that insulin decreases gene expression of the major
adipose triglyceride lipase (ATGL) [27]. Moreover, tran-
scriptional activation and phosphorylation of members of
the perilipin family are reportedly affected by elevated in-
sulin and glucose levels [28]. We hence studied the puta-
tive role of PLIN5 in the physiological regulation of insu-
lin sensitivity, in a model in which lipid overload was
physiologically induced and in which blunted insulin
sensitivity could not be attributed to secondary effects of
long-term pathophysiological consequences of insulin
resistance, like hyperglycaemia or hyperinsulinaemia.
Therefore, we employed our studies in a model of
prolonged fasting (60 h) in humans, which we previously
published [29]. In this study, prolonged fasting resulted in
a profound decrease in insulin sensitivity and an increase
in IMCL content, while insulin and glucose levels were in
the low end of the physiological range. Interestingly,
rodent data indicate that—at least in cardiac muscle—a
prolonged fast was paralleled by increased myocardial fat
content and induction of PLIN5 [19]. Therefore, we
hypothesised a role for PLIN5 in modulating fasting-
induced insulin resistance.
As we previously observed that genetically promoting
PLIN5 resulted in increased LD size [22], we combined
studies in whole-muscle homogenates with detailed quantita-
tive confocal fluorescence microscopy-based morphometric
data permitting analysis of individual LDs under fed and
fasted conditions.
Methods
Ethics statement The study protocol was approved by the
institutional Medical Ethical Committee. All participants
(n=11) gave written informed consent prior to participating
in the study. This study has been registered in the Nederlands
Trial Register (www.trialregister.nl) with registration number
NTR 2042. The plasma data presented in this paper originate
from previously published work [29].
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Participants and study protocol A detailed protocol of the
present study has previously been published elsewhere [29].
In brief, 12 young, normoglycaemic lean men were studied in
the fasted (60 h fast) or fed state, in a randomised crossover
design with a 2 week washout period in between. None of the
participants was engaged in sports>2 h per week. To ensure
compliance to the intervention, the entire study was performed
in a respiration chamber. In the fasted state only energy-free
drinks were consumed. In the fed state participants were fed in
energy balance (with 50%, 35% and 15% of energy intake
consumed as carbohydrates, fat and protein, respectively).
Post-intervention (60 h fast or fed), a hyperinsulinaemic–
euglycaemic clamp was performed (40 mUm−2 min−1 insulin
combined with infusion of [6,6-2H2]glucose to measure rates
of glucose disposal (rate of disappearance [Rd]). Prior to the
clamp, a biopsy was taken from the vastus lateralis muscle.
One portion was processed for mitochondrial capacity assays
(high-resolution respirometry to assess ADP-driven state 3
respiration in permeabilised muscle fibres using octanoyl-
CoA, glutamate and succinate as substrates). Maximal
uncoupled respiration was measured upon carbonyl cyanide-
4-(trifluoromethoxy)phenylhydrazone titration (FCCP).
Oxygen flux was normalised to mitochondrial content based
upon mtDNA copy number) [29]. Another portion of the
sample was frozen directly in melting isopentane, and stored
at −80°C for qRT-PCR analysis, western blotting and quanti-
tative (immuno)fluorescence microscopy. Muscle insulin sen-
sitivity was expressed as insulin sensitivity index (SI-index)
and was calculated as (Rd insulin stimulated−Rd basal) /
(plasma insulin×plasma glucose). Confocal immunofluores-
cence is based upon nine individuals. Characteristics of all
participants are presented in Table 1.
Quantitative real-time PCR RNAwas isolated from approx-
imately 30 mg muscle tissue essentially according to
Chomczynski et al [30]. Quantitative real-time RT-PCR was
performed as described previously [31, 32]. Primers and
probes are presented in electronic supplementary material
(ESM) Table 1. Gene expression data for PLIN5were normal-
ised over RPLP0.
Western blotsWestern blots were performed using antibodies
against PLIN5 (Progen GP31; Progen Biotechnik,
Heidelberg, Germany) and SR-actin (A-2172; Sigma, St
Louis, MO, USA). Infrared-tagged secondary antibodies
(IRDye; LI-COR, Lincoln, NE, USA) were used to visualise
and quantify the relevant protein bands (Odyssey Infrared
Imaging system; LI-COR Biosciences, Westburg, Leusden,
the Netherlands).
Histochemical analysis Fresh cryosections (7μm) of samples
from the fed and fasted state were cut and thaw-mounted on a
single glass slide to minimise variety in staining intensity.
Initial quantification of IMCL was performed by Oil-Red-O
staining [33]. To allow valid LD morphometry, sections
displaying freezing damage were discarded. As a result, full
morphometric analyses were performed on 3,595±522 and
4,766±489 LDs per participant (n=9) in the fed and fasted
state, respectively. For quantification of PLIN5, sections were
fixed in 3.7% vol./vol. formaldehyde in PBS for 30 min,
washed for 5 min with PBS, blocked for 45 min with blocking
buffer (150 mmol/l NaCl, 20 mmol/l Tris pH 6.8 and 2%
wt/vol. BSA) and permeabilised with 0.25% wt/vol.
Triton-X 100 (648466; Merck, Darmstadt, Germany).
Subsequently, sections were washed with PBS for 5 min
followed by a 1 h incubation with primary antibodies against
laminin (L9393; Sigma) and PLIN5 (GP31; Progen
Biotechnik, Heidelberg, Germany) in blocking buffer at room
temperature. LDs were visualised using Bodipy 493/503
(Molecular Probes, Leiden, the Netherlands). Sections were
incubated for 1.5 h along with the appropriate secondary
antibodies conjugated with Alexa Fluor 405 or Alexa Fluor
647 (Invitrogen, Groningen, the Netherlands) at 37°C and
mounted with Mowiol (5886; Merck).
Confocal image acquisition and analysis Multiple sliced
Z-stacks were acquired on a Leica TCS SPE confocal micro-
scope using a ×63 1.3 N.A. oil immersion objective with a 1.1
optical zoom at 2,048 by 2,048 pixels resulting in a pixel size
of 77 by 77 nm. Laminin–Alexa Fluor 405, Bodipy 493/503
and PLIN5–Alexa Fluor 647 were imaged using the 405, 488
and 635 nm laser lines, respectively. Emission was detected at
415–460, 500–560 and 650–750 nm for, respectively,
Laminin–Alexa Fluor 405, Bodipy 493/503 and PLIN5–
Alexa Fluor 647. To permit valid quantification of the fluores-
cence signal from PLIN5–Alexa Fluor 647, pixel saturation
was prevented. Z-stacks were acquired for deconvolution
purposes (Huygens Essential software; Scientific Volume
Imaging, Hilversum, the Netherlands) and analysed using
ImageJ (NIH, Bethesda, Maryland, USA) [34]. Intensity of
PLIN5 staining was analysed on the non-deconvoluted
images. LDs coated with PLIN5 (co-localisation with
PLIN5) and devoid of PLIN5 were quantified using a
Table 1 Characteristics of participants (n= 12)
Variable Mean ± SEM
Age (years) 23.6 ± 1.0
Body weight (kg) 78.5 ± 2.5
Fat-free mass (kg) 65.9 ± 1.8
Height (m) 1.86 ± 0.02
BMI (kg/m2) 22.6 ± 0.5
Maximal aerobic capacity ([ml O2] kgFFM
−1min−1) 57.5 ± 1.5
FFM, fat-free mass
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custom-written routine in Matlab R2012a (The Mathworks,
Natick, MA, USA).
Statistical analyses Results are presented as mean±SEM.
Statistical analyses were performed using SPSS version 21.0
(SPSS, Chicago, IL, USA). Statistical comparisons between
conditions were performed using paired t tests. Pearson’s
correlation coefficients were used to describe the linear
association between variables. p < 0.05 was considered
statistically significant.
Results
Plasma variables We previously reported a significant
increase in circulatory NEFA levels (∼ ninefold) and a signif-
icant decrease in plasma glucose values, insulin levels and
insulin sensitivity (glucose infusion rate and SI-index) upon
fasting [29]. These data indicate that fasting created the
warranted condition of profound insulin resistance and
increased circulatory NEFA in the absence of hyperglycaemia
or hyperinsulinaemia for the present study.
IMCL content and insulin resistance Fasting significantly
augmented IMCL content (1.67±0.32 arbitrary units [AU] in
the fed state; 4.60±0.72 AU after fasting) [29]. Interestingly,
the increase in IMCL (IMCL in the fasted state minus IMCL
in the fed state) upon fasting correlated positively (r=0.657;
p=0.028) with the decrease in the SI-index (SI-index in the
fasted state minus the SI-index in the fed state) (Fig. 1),
suggesting that promoting IMCL storage capacity ameliorates
fasting-induced insulin resistance.
Morphometric analysis As changes in LD size [6] may
contribute to the development of insulin resistance we
employed microscopy to examine LD size and number.
Fasting promoted LD size (0.26±0.01 vs 0.32±0.01 μm2;
p<0.01) and number (0.039±0.004 vs 0.048±0.003 μm−2;
p<0.05) (Fig. 2a, b). LD size distribution analyses revealed a
drop in the percentage of small LDs (≤0.20μm2) upon fasting,
whereas the percentage of large LDs (≥0.35μm2) significantly
increased (Fig. 2c).
PLIN5 content on individual LDs Conventional analysis of
whole-muscle lysates revealed that fasting had no effect on
PLIN5mRNA (1.04±0.13 vs 1.11±0.11; p=0.72; Fig. 3a) or
PLIN5 protein content (10.4±3.1 vs 10.3±2.8 AU; p=0.99)
(Fig. 3b). Muscle lysates were made from sections with equal
distribution between type I and type II muscle fibres in the fed
and fasted state (50±2% and 52±4% type I fibres in the fed
Fig. 1 Correlation of the change in IMCL content and SI-index
(μmol min−1 kg−1 pmol−1 l) upon prolonged fasting (n= 11), suggesting
that promoting the capacity to store lipids as IMCL ameliorates fasting-
induced insulin resistance. This correlation appears to be driven by
PLIN5-coated LDs (Fig. 6a, b)
Fig. 2 LD size and number increased upon prolonged fasting. (a)
Representative images of muscle fibres from the fed and fasted state
(magnification× 70; scale bar, 15 μm). LDs are stained in green and cell
membranes in blue. (b) Quantification of LD size and number relative to
cell area. (c) Frequency distribution of LD size. Data are based upon
examination of 3,595 ± 522 and 4,766 ± 489 LDs per participant (n= 9)
in the fed and fasted state and presented as mean ± SEM. *p< 0.05 and
**p< 0.01 vs fed state. White bars, fed state; black bars, fasted state
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and fasted state, respectively, and 50±2% and 48±4% type II
fibres in the fed and fasted state, respectively). PLIN5 is
known to be more abundantly expressed in type I fibres.
Hence we selected predominantly type I fibres for quantitative
high-resolution confocal immunofluorescence microscopy.
We simultaneously quantified individual LD size and PLIN5
protein content (Fig. 4a; see ESM Videos 1 and 2 for three-
dimensional animated images) by microscopy. In line with the
observation in whole-muscle lysates, we observed that total
PLIN5 protein content was unaffected by fasting (2,181±202
vs 2,443 ± 312 AU; p= 0.276 in the fed and fasted state,
respectively, Fig. 4b). To avoid bias introduced by a potential
fasting-induced fibre type shift, a similar percentage of type
I muscle fibres in the fed (82±6%) and in the fasted state
(87±6%) was examined.
Given the putative role of PLIN5 in controlling lipolysis
and sequestering fatty acids in LDs by covering the LD
surface [35], we examined the fraction of PLIN5 protein
associated with LDs. Although total PLIN5 content was not
affected by fasting, the fraction of PLIN5 protein directly
associated with LDs significantly increased upon fasting from
14.9 ± 2.2% to 18.7 ±1.3% (Fig. 4c), suggesting a fasting-
induced redistribution of PLIN5 from cytosolic sites to the
LD surface. Using this novel microscopical approach we
could also delineate LDs with high levels of PLIN5 protein
(PLIN5+) from LDs devoid of PLIN5 (PLIN5−).
Upon making the distinction between PLIN5+ and PLIN5
− LDs, we observed that the fasting-mediated increase in LD
size as well as number was entirely accounted for by PLIN5+
LDs whereas PLIN5− LDs did not change in size or number
(Fig. 5a, b). Although these data do not permit statements on
causality, they indicate involvement of PLIN5 in the
fasting-mediated increase in LD size and number.
We also observed that the correlation between the change
in myocellular fat deposition (change in IMCL) and insulin
sensitivity, which was observed upon inclusion of all LDs
(r= 0.657, p= 0.028; Fig. 1), was less strong when only
PLIN5+ LDs were taken into account (r=0.587) but still
approached the level of significance (p= 0.096; Fig. 6a).
This was in contrast to LDs devoid of PLIN5, for which this
correlation completely vanished (r = −0.381, p = 0.311;
Fig. 6b).
Myocellular fat accumulation is not only associated with
compromised insulin sensitivity but also with the
development of mitochondrial dysfunction [29], a process
referred to as mitochondrial lipotoxicity [36]. Using a variety
of substrates, we observed that the reduction in mitochondrial
function (ADP-driven state 3 respiration, as well as FCCP-
Fig. 3 PLIN5 gene expression
(n = 12) (a) and PLIN5 protein
content (n = 11) (b) measured in
whole-muscle lysates in the fed
and the fasted state. Data are
presented as mean ± SEM
Fig. 4 (a) Representative three-dimensional images of LD (green) and
PLIN5 protein localisation (red) in the fed and fasted state (scale bar,
7 μm). Please visit ESM Videos 1 and 2 for animated three-dimensional
reconstruction. (b) Average PLIN5 protein content in muscle fibres mea-
sured as intensity of PLIN5 staining. (c) Percentage of PLIN5 protein
content associated with LDs. Data are based upon examination of
3,595 ± 522 and 4,766 ± 489 LDs per participant (n = 9) in the fed and
fasted state and presented as mean ± SEM, *p< 0.05 vs fed state
1044 Diabetologia (2016) 59:1040–1048
mediated maximal uncoupled respiration) upon fasting
correlated with the increase in LD size upon fasting
(r=0.896, p=0.006 for octanoyl-CoA; r=0.795, p=0.033
for octanoyl-CoA with glutamate; r= 0.873, p= 0.010 for
octanoyl-CoA with glutamate and succinate and r=0.853,
p=0.015 for maximal uncoupled respiration; Fig. 7a, d, g
and j, respectively). These correlations were maintained if
only PLIN5+ LDs were taken into account (Fig. 7b, e, h, k)
but, strikingly, were absent for PLIN5− LDs (Fig. 7c, f, i, l).
Discussion
Here we studied the hypothesis that the LD coat protein
PLIN5 increases upon fasting and that PLIN5 is involved in
the maintenance of insulin sensitivity under conditions of lipid
overload. To this end, we took advantage of a physiological
model of insulin resistance in humans—prolonged (60 h)
fasting. We showed that the previously reported increase in
IMCL upon fasting [29] originates from an increase in both
number and size of LDs. Although total PLIN5 content was
not affected by fasting, a subcellular redistribution of PLIN5
was observed after fasting, resulting in increased coverage of
the LDs with PLIN5. Interestingly, the increase in LD size and
number was entirely explained by increases in LD size and
number of LDs coated with PLIN5. No such change was
observed in droplets devoid of PLIN5. Moreover, we showed
that the individuals most capable of increasing muscle fat
content upon fasting had the lowest reduction in insulin
sensitivity and mitochondrial function. Also, this observation
was entirely accounted for by LDs coated with PLIN5. Jointly,
these data indicate that the fasting-mediated increase of PLIN5
on the LD surface is part of the adaptive response to fasting to
alleviate lipid-induced insulin resistance and to maintain
mitochondrial function.
Most of our knowledge on the response of PLIN5 to fasting
originates from cardiac muscle in rodent studies [18–20].
These papers indicate that fasting promotes PLIN5 gene
expression and protein content in cardiac muscle, whereas in
mouse skeletal muscle (gastrocnemius and soleus) PLIN5
protein content appeared to be unaffected by a 24 h fast
[18]. The effect of fasting on PLIN5 content in human skeletal
muscle has not yet been examined. In line with animal data in
skeletal muscle we observed that total PLIN5 content in
muscle was unaffected upon fasting. Rather, fasting resulted
in redistribution of PLIN5 from cytosolic pools to the LD
surface. The fraction of the LDs coated with PLIN5 increased
significantly upon fasting, along with an increase in LD size
and the fraction of PLIN5 protein content associated with the
LD.
Although PLIN5 is best known as an LD coat protein,
subcellular fractionation studies revealed the presence of
PLIN5 in cytosolic fractions [19]. At present, it is not known
whether the cytosolic PLIN5 pool represents unbound PLIN5
or PLIN5 that is somehow located to (yet to be identified)
subcellular structures. Hence, it is not known whether the
observed redistribution of PLIN5 is in fact a targeted translo-
cation from a defined locus to the LD or whether it represents
Fig. 5 Changes in LD size (a) and number (b) are accounted for by
PLIN5+ LDs. Data are based upon examination of 3,595 ± 522 and
4,766 ± 489 LDs per participant (n = 9) in the fed and fasted state and
are presented as mean ± SEM, *p < 0.05 or **p < 0.01 vs fed state;
†p < 0.001 PLIN5+ vs PLIN5− LDs. White bars, fed state; black bars,
fasted state
Fig. 6 Correlations of the
fasting-induced changes (fasted–
fed) in the number of PLIN5+
LDs (perμm2) (a) and the number
of PLIN5− LDs (per μm2) (b)
with the reduction in SI-index
(μmol min−1 kg−1 pmol−1 l)
(n = 9)
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expansion of nano-scaled LDs coated with PLIN5 that did not
exceed the lower detection limit of the microscope in the fed
state (and hence were considered cytosolic) but that became
detectable upon fasting. It should be noted, however, that
fasting resulted in a pool of large-sized LDs decorated with
PLIN5 (PLIN5+ LDs) whereas the smaller LDs were devoid
of PLIN5. This reduces the likelihood that the pool of
cytosolic PLIN5 in fact represents a pool bound to nano-
scaled LDs and favours the concept of fasting-mediated
redistribution of PLIN5.
In the present model of physiological insulin resistance,
PLIN5+ LDs were more numerous and larger than PLIN5−
LDs. Hence, LD expansion may originate from coating of the
LD with PLIN5 and its inhibitory effect on myocellular LD
lipolysis, either by binding to the major triglyceride lipase
ATGL [37] or by binding to the co-activator of ATGL,
CGI-58 [38]. In trained athletes, high levels of IMCL and high
insulin sensitivity accompany high levels of PLIN5 [16, 17],
indicating that PLIN5 may modulate insulin sensitivity under
conditions of high lipid load. Importantly, delineation of
PLIN5+ and PLIN5− LDs for the first time provides experi-
mental support to the notion that increased myocellular fat
content does not necessarily impede insulin sensitivity,
provided that the excess fat is stored in PLIN5+ LDs. Thus,
expanding the pool of LDs decorated with PLIN5 could be
considered an adaptive response to fasting to maintain LD
dynamics and prevent insulin resistance. Interestingly, we
recently showed that individual LDs coated with PLIN5
Fig. 7 Correlations of the fasting-induced changes in LD size (μm2) of
all LDs (a, d, g, j), PLIN5+ LDs (b, e, h, k) and PLIN5− LDs (c, f, i, l)
with changes in mitochondrial ADP-driven state 3 (S3) respiration
(pmol mg−1 s−1 [mtDNA copy no. × 104]−1) in permeabilised muscle
fibres on a lipid-derived substrate octanoyl-CoA (MO) (a–c), octanoyl-
CoA+ glutamate (MOG) (d–f) and octanoyl-CoA+ glutamate + succi-
nate (MOGS) (g–i) and during maximal uncoupling (j–l) (n= 7)
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sequester more bioactive insulin-desensitising lipids than LDs
devoid of PLIN5 [39], providing a possible explanation as to
why storage of excess fat in PLIN5+ LDs ameliorates
lipid-induced insulin resistance.
PLIN5 has also been hypothesised to modulate lipotoxicity
by promoting interaction and/or intimate physical association
of LDs with mitochondria [21, 40] and to promote oxidative
gene expression [40] to facilitate mitochondrial degradation of
the fatty acids released from LD lipolysis. Accordingly,
PLIN5 may be involved in the prevention of mitochondrial
lipotoxicity. In that respect it is of interest to note that the
fasting-mediated decline in mitochondrial function (measured
as state 3 ADP-driven mitochondrial oxygen uptake and
FFCP-mediated maximal uncoupled respiration on a variety
of substrates) correlated positively with the fasting-mediated
increase in LD size. Upon making the distinction between
PLIN5+ and PLIN5− LDs, this correlation appeared to
originate from PLIN5+ LDs and was completely absent for
PLIN5− LDs for state 3 respiration as well as for maximally
uncoupled respiration, irrespective of the substrate used. This
again supports the notion that decoration of LDs with PLIN5
may prevent mitochondrial lipotoxicity upon fasting, possibly
via expansion of the capacity for inert lipid storage. This no-
tion substantiates our previously reported observation that in
muscle of Zucker diabetic fatty rats PLIN5 protein content
correlates positively with mitochondrial function [40].
Jointly, our observation that expansion of PLIN5+ LDs
ameliorates mitochondrial lipotoxicity and lipid-induced
insulin resistance is in line with rodent data indicating a
protective role for PLIN5 in lipid-induced insulin resistance
[22, 23] and hepatic lipotoxicity [41].
Next to the methodological advance permitting analysis at
the level of individual LDs, a major strength of the present
study is that, in contrast to most other models of insulin resis-
tance or type 2 diabetes, its design permits conclusions to be
drawn on the role of PLIN5 at the very early stages of insulin
resistance development. We studied drug-naive, healthy, lean
and young men in whom glucose and insulin were well within
the normal physiological range. Thus, our observations cannot
be attributed to consequences secondary to the pathological
state that parallels most models of insulin resistance and hence
likely reflect physiological adaptive responses to the very
early insulin-resistant state. Maintenance of these adaptive
responses may blunt the pathogenesis of insulin resistance.
Myocellular lipid handling is affected by muscle fibre type
distribution as well as by sex [42]. In the present study, we
carefully considered muscle fibre type distribution as a poten-
tial confounder. For data on whole-muscle cell lysates (PLIN5
protein content and gene expression) we ensured equal distri-
bution of type I and type II muscle fibres in the fed and the
fasted state. Under untreated and physiological conditions,
type I fibres store more lipid and express PLIN5 more abun-
dantly. Hence, we purposely focused our microscopy on type I
muscle fibres, with a similar fraction of type I fibres being
examined in the fed and fasted state. With respect to sex, it
is important to note that in the present study we only examined
men. Therefore, extrapolation of the present findings to
women must be done with care, especially given the sex
differences previously reported for myocellular lipid handling
[42], lipid-induced insulin resistance [43], response to fasting
[44] and PLIN5 content [45].
In conclusion, the present study shows that PLIN5 protein
content did not increase in human skeletal muscle upon
fasting, although fasting resulted in a redistribution of
PLIN5 from a non-LD-associated cytosolic pool towards the
LDs. The ability to store excess fat in skeletal muscle in
PLIN5+ LDs upon a prolonged fast associates with blunting
of fasting-induced insulin resistance and mitochondrial
dysfunction. These data support a role for PLIN5 in the
mitigation of fasting-mediated lipotoxicity.
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